BlinkLab (ASX: BB1) — Company Overview, News & Financial Data
BlinkLab is a digital healthcare technology company developing mobile diagnostic tools for neurodevelopmental and psychiatric conditions.
BlinkLab
BlinkLab is a digital healthcare technology company developing mobile diagnostic tools for neurodevelopmental and psychiatric conditions. Founded as a spin-off based on technology developed at Princeton University, the company utilizes smartphone-based artificial intelligence and computer vision to deliver objective reflex-based assessments, such as acoustic startle response and prepulse inhibition. Its core platform is designed to assist clinicians in the early screening and diagnosis of autism spectrum disorder and attention deficit hyperactivity disorder. Headquartered in Perth, Australia, the company conducts clinical studies and research collaborations with academic institutions and healthcare providers across Australia, Europe, and the United States.
Snapshot
Operations
Products and/or services of BlinkLab
- Autism Diagnostic Platform: Smartphone-based digital healthcare tool utilizing computer vision and artificial intelligence to evaluate sensory gating and acoustic startle reflex responses, aiding clinicians in early autism spectrum disorder assessments across clinical and remote patient environments.
- ADHD Assessment Expansion: Clinical testing platform extending smartphone reflex measurements to evaluate attention deficit hyperactivity disorder, collecting neurobehavioral biomarkers across pediatric and adult cohorts to support diagnostic expansion across European and international clinical trial sites.
- Research SaaS Portal: Cloud-based diagnostic dashboard and testing infrastructure providing remote neurobehavioral evaluation tools for academic medical centers and research institutions conducting large-scale studies on neurodevelopmental, psychiatric, and neurological conditions.
- North American Clinical Operations: Clinical validation network partnering with medical centers including Drexel University and Rush University Medical Center, executing clinical trials and gathering empirical dataset evidence to fulfill regulatory submission requirements with health authorities.
- European Clinical Trial Network: Clinical research partnerships and testing programs across the Netherlands and broader Europe, including Erasmus MC and Mental Care Group, evaluating smartphone-based reflex testing for neurodevelopmental and psychiatric diagnostic applications.
- Australian Research Operations: Clinical trial infrastructure and institutional research collaborations across Australia, including Monash University, managing study participant recruitment, local data compliance, and trial execution within domestic healthcare and university hospital networks.
BlinkLab executive team
- Dr. Hendrikus Johannes Boele M.D., Ph.D.CEO, MD & Director
- Dr. Anton Uvarov BioChem, MBA, MedGen, Ph.D.Co-Founder & Executive Director
- Mr. Cornelis Pieter Boele M.A.Co-Founder & CTO
- Dr. Sebastiaan K.E Koekkoek Ph.D.Co-Founder & CSO
- Seth SherryDirector of Operations
- Myrthe Ottenhoff Ph.D.Chief Medical Officer
- Mr. Christopher Bryan James Achurch B.Com., C.A.Company Secretary